title: Long-term anticoagulant effects of CYP2C9 and VKORC1 genotypes in phenprocoumon users.
authors.forename: T I
authors.initials: TI
authors.lastname: Verhoef
authors.forename: W K
authors.initials: WK
authors.lastname: Redekop
authors.forename: H
authors.initials: H
authors.lastname: Hegazy
authors.forename: A
authors.initials: A
authors.lastname: de Boer
authors.forename: A H
authors.initials: AH
authors.lastname: Maitland-van der Zee
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D065729:Cytochrome P-450 CYP2C9; D005838:Genotype; D006801:Humans; D006899:Mixed Function Oxygenases / Q000235:genetics*; D010644:Phenprocoumon / Q000627:therapeutic use*; D064417:Vitamin K Epoxide Reductases
chemical_list: D000925:Anticoagulants; D006899:Mixed Function Oxygenases; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; C578523:VKORC1 protein, human; D064417:Vitamin K Epoxide Reductases; D010644:Phenprocoumon